This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04658/identifier/drugbank/
dctermshttp://purl.org/dc/terms/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04658/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/property/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04658/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB04658/identifier/pubchem-substance/

Statements

Subject Item
n2:DB04658
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB04658 n8:DB04658
dcterms:title
(1S,2R,3S,4R,5S)-8-AZABICYCLO[3.2.1]OCTANE-1,2,3,4-TETROL
adms:identifier
n10:CGB n11:124434 n12:DB04658 n13:46505662
n3:IUPAC-Name
n4:271B478C-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4792-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4791-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B478E-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B478F-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4790-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B478A-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4788-363D-11E5-9242-09173F13E4C5 n4:271B478B-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4789-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4798-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4799-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4793-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4794-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4796-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4795-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4797-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B479E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B47A0-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B47A1-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B479D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B479C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B479F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B478D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B479A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B479B-363D-11E5-9242-09173F13E4C5